NAS:BABY (USA) Also trade in: Germany

Natus Medical Inc

$ 26.65 -0.02 (-0.07%)
On watch
Volume: 6,777 Avg Vol (1m): 219,413
Market Cap $: 906.25 Mil Enterprise Value $: 952.35 Mil
P/E (TTM): 0.00 P/B: 2.44
Earnings Power Value 12.51
Net Current Asset Value 0.09
Tangible Book 2.62
Projected FCF 20.27
Median P/S Value 34.77
Graham Number 0
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
1Y (-%)

Financial Strength : 7/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 0.54
Cash-To-Debt ranked lower than
71.21% of 330 companies
in the Medical Devices industry.
Industry Max: 504099, Med: 2.32, Min: -16.34
BABY: 0.54
Ranked among companies with meaningful Cash-To-Debt only.
Cash-To-Debt range over the past 10 years
Min: 0.32, Med: 41.06, Max: 10000
Current: 0.54
0.32
10000
Equity-to-Asset 0.58
Equity-to-Asset ranked lower than
52.75% of 309 companies
in the Medical Devices industry.
Industry Max: 0.99, Med: 0.63, Min: -24.4
BABY: 0.58
Ranked among companies with meaningful Equity-to-Asset only.
Equity-to-Asset range over the past 10 years
Min: -1.79, Med: 0.82, Max: 0.94
Current: 0.58
-1.79
0.94
Debt-to-Equity 0.27
Debt-to-Equity ranked lower than
55.00% of 220 companies
in the Medical Devices industry.
Industry Max: 11.69, Med: 0.3, Min: 0.01
BABY: 0.27
Ranked among companies with meaningful Debt-to-Equity only.
Debt-to-Equity range over the past 10 years
Min: -0.1, Med: 0.07, Max: 0.37
Current: 0.27
-0.1
0.37
Debt-to-EBITDA -4.05
Debt-to-EBITDA ranked lower than
72.15% of 158 companies
in the Medical Devices industry.
Industry Max: 3384.46, Med: 1.98, Min: 0.02
BABY: -4.05
Ranked among companies with meaningful Debt-to-EBITDA only.
Debt-to-EBITDA range over the past 10 years
Min: -4.05, Med: 1.92, Max: 16.94
Current: -4.05
-4.05
16.94
Interest Coverage 2.25
Interest Coverage ranked lower than
96.23% of 212 companies
in the Medical Devices industry.
Industry Max: 10000, Med: 66.37, Min: 0.03
BABY: 2.25
Ranked among companies with meaningful Interest Coverage only.
Interest Coverage range over the past 10 years
Min: 1.86, Med: 68.15, Max: 158.01
Current: 2.25
1.86
158.01
Piotroski F-Score 5
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.88
DISTRESS
GREY
SAFE
Beneish M-Score -2.69
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC 2.32%
WACC 1.98%

Profitability & Growth : 7/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % 2.77
Operating Margin ranked lower than
50.32% of 312 companies
in the Medical Devices industry.
Industry Max: 1148.46, Med: 1.96, Min: -47867.72
BABY: 2.77
Ranked among companies with meaningful Operating Margin only.
Operating Margin range over the past 10 years
Min: 1.75, Med: 8.71, Max: 14.87
Current: 2.77
1.75
14.87
Net Margin % -9.63
Net Margin ranked lower than
57.37% of 312 companies
in the Medical Devices industry.
Industry Max: 15538.12, Med: 1.4, Min: -45900
BABY: -9.63
Ranked among companies with meaningful Net Margin only.
Net Margin range over the past 10 years
Min: -9.63, Med: 6.1, Max: 11.15
Current: -9.63
-9.63
11.15
ROE % -12.44
ROE ranked lower than
57.24% of 304 companies
in the Medical Devices industry.
Industry Max: 51.97, Med: 0.95, Min: -2921.66
BABY: -12.44
Ranked among companies with meaningful ROE only.
ROE range over the past 10 years
Min: -12.44, Med: 4.77, Max: 10.54
Current: -12.44
-12.44
10.54
ROA % -7.60
ROA ranked lower than
54.52% of 332 companies
in the Medical Devices industry.
Industry Max: 1204.95, Med: -0.26, Min: -2520.55
BABY: -7.6
Ranked among companies with meaningful ROA only.
ROA range over the past 10 years
Min: -7.6, Med: 3.98, Max: 8.3
Current: -7.6
-7.6
8.3
ROC (Joel Greenblatt) % -40.68
ROC (Joel Greenblatt) ranked higher than
55.05% of 327 companies
in the Medical Devices industry.
Industry Max: 8175, Med: 3.87, Min: -323166.67
BABY: -40.68
Ranked among companies with meaningful ROC (Joel Greenblatt) only.
ROC (Joel Greenblatt) range over the past 10 years
Min: -40.68, Med: 26.53, Max: 56.94
Current: -40.68
-40.68
56.94
3-Year Total Revenue Growth Rate 12.20
3-Year Revenue Growth Rate ranked higher than
71.65% of 254 companies
in the Medical Devices industry.
Industry Max: 300.7, Med: 4.3, Min: -100
BABY: 12.3
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
3-Year Revenue Growth Rate range over the past 10 years
Min: -61.9, Med: 11.55, Max: 38.3
Current: 12.3
-61.9
38.3
3-Year Total EBITDA Growth Rate -50.40
3-Year EBITDA Growth Rate ranked lower than
78.88% of 232 companies
in the Medical Devices industry.
Industry Max: 109.5, Med: 7.5, Min: -344.2
BABY: -50.3
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
3-Year EBITDA Growth Rate range over the past 10 years
Min: 0, Med: -6, Max: 863.2
Current: -50.3
0
863.2

» BABY's 30-Y Financials

Financials (Next Earnings Date: 2019-07-25)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NAS:BABY

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Medical Devices » Medical Devices    NAICS : 334510    SIC : 3845
Compare XTER:DRW3 HKSE:01302 SHSE:600587 NAS:TCMD NAS:AXGN XTER:SBS OSTO:ARJO B SZSE:300238 NAS:XENT NAS:OFIX XPAR:GBT SZSE:300273 TSE:6960 SZSE:300298 SZSE:300206 ROCO:8406 SHSE:603579 NAS:VRAY SHSE:603387 NYSE:CRY
Traded in other countries NM4.Germany
Address 6701 Koll Center Parkway, Suite 120, Pleasanton, CA, USA, 94566
Natus Medical Inc provides healthcare products related to newborn care and neurology. Its products are used to diagnose and treat newborn medical conditions, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and mobility disorders. The firm operates in two business units: neurology and newborn care. The neurology business generates the majority of revenue and includes products and services for diagnostic electroencephalography, intensive care unit monitoring, electromyography, and sleep analysis. The newborn care business sells products and services for newborn care, such as hearing screening, brain injury, thermoregulation, and jaundice management products. Natus Medical receives the majority of its revenue from sales in the United States.

Ratios

Current vs industry vs history
PB Ratio 2.44
PB Ratio ranked higher than
58.71% of 310 companies
in the Medical Devices industry.
Industry Max: 1180, Med: 3.06, Min: 0.07
BABY: 2.44
Ranked among companies with meaningful PB Ratio only.
PB Ratio range over the past 10 years
Min: 0.79, Med: 2.4, Max: 4.26
Current: 2.44
0.79
4.26
PS Ratio 1.72
PS Ratio ranked higher than
63.95% of 294 companies
in the Medical Devices industry.
Industry Max: 1136.36, Med: 3.15, Min: 0.05
BABY: 1.72
Ranked among companies with meaningful PS Ratio only.
PS Ratio range over the past 10 years
Min: 0.95, Med: 2.24, Max: 4.42
Current: 1.72
0.95
4.42
Price-to-Free-Cash-Flow 36.06
Price-to-Free-Cash-Flow ranked lower than
85.05% of 107 companies
in the Medical Devices industry.
Industry Max: 3239, Med: 26.44, Min: 5.07
BABY: 36.06
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
Price-to-Free-Cash-Flow range over the past 10 years
Min: 12.63, Med: 29.37, Max: 159.78
Current: 36.06
12.63
159.78
Price-to-Operating-Cash-Flow 26.81
Price-to-Operating-Cash-Flow ranked lower than
85.83% of 127 companies
in the Medical Devices industry.
Industry Max: 1586.78, Med: 20.01, Min: 3.03
BABY: 26.81
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 10.19, Med: 24.52, Max: 75.49
Current: 26.81
10.19
75.49
EV-to-EBIT -15.59
EV-to-EBIT ranked lower than
94.25% of 174 companies
in the Medical Devices industry.
Industry Max: 18456.56, Med: 24.76, Min: 0.63
BABY: -15.59
Ranked among companies with meaningful EV-to-EBIT only.
EV-to-EBIT range over the past 10 years
Min: -277.9, Med: 22.2, Max: 197.6
Current: -15.59
-277.9
197.6
EV-to-EBITDA -38.74
EV-to-EBITDA ranked lower than
73.94% of 188 companies
in the Medical Devices industry.
Industry Max: 18456.56, Med: 18.14, Min: 0.62
BABY: -38.74
Ranked among companies with meaningful EV-to-EBITDA only.
EV-to-EBITDA range over the past 10 years
Min: -82.2, Med: 16.6, Max: 5653.1
Current: -38.74
-82.2
5653.1
EV-to-Revenue 1.84
EV-to-Revenue ranked higher than
65.05% of 309 companies
in the Medical Devices industry.
Industry Max: 17078.6, Med: 3.73, Min: 0.05
BABY: 1.84
Ranked among companies with meaningful EV-to-Revenue only.
EV-to-Revenue range over the past 10 years
Min: 0.8, Med: 2.2, Max: 4.4
Current: 1.84
0.8
4.4
Shiller PE Ratio 94.26
Shiller PE Ratio ranked lower than
63.79% of 58 companies
in the Medical Devices industry.
Industry Max: 636.22, Med: 49.95, Min: 2.03
BABY: 94.26
Ranked among companies with meaningful Shiller PE Ratio only.
Shiller PE Ratio range over the past 10 years
Min: 53.07, Med: 77.55, Max: 115.5
Current: 94.26
53.07
115.5
Current Ratio 1.70
Current Ratio ranked higher than
58.33% of 324 companies
in the Medical Devices industry.
Industry Max: 563.8, Med: 2.71, Min: 0.03
BABY: 1.7
Ranked among companies with meaningful Current Ratio only.
Current Ratio range over the past 10 years
Min: 1.3, Med: 3.23, Max: 16.01
Current: 1.7
1.3
16.01
Quick Ratio 1.18
Quick Ratio ranked higher than
58.33% of 324 companies
in the Medical Devices industry.
Industry Max: 563.8, Med: 2.03, Min: 0.02
BABY: 1.18
Ranked among companies with meaningful Quick Ratio only.
Quick Ratio range over the past 10 years
Min: 0.91, Med: 2.53, Max: 15.09
Current: 1.18
0.91
15.09
Days Inventory 132.03
Days Inventory ranked higher than
64.97% of 294 companies
in the Medical Devices industry.
Industry Max: 990.33, Med: 143.61, Min: 0.63
BABY: 132.03
Ranked among companies with meaningful Days Inventory only.
Days Inventory range over the past 10 years
Min: 100.58, Med: 115.36, Max: 132.84
Current: 132.03
100.58
132.84
Days Sales Outstanding 78.29
Days Sales Outstanding ranked lower than
72.10% of 276 companies
in the Medical Devices industry.
Industry Max: 907.73, Med: 69.21, Min: 0.13
BABY: 78.29
Ranked among companies with meaningful Days Sales Outstanding only.
Days Sales Outstanding range over the past 10 years
Min: 78.29, Med: 89.45, Max: 112.34
Current: 78.29
78.29
112.34
Days Payable 42.02
Days Payable ranked lower than
65.90% of 261 companies
in the Medical Devices industry.
Industry Max: 912.5, Med: 58.34, Min: 1
BABY: 42.02
Ranked among companies with meaningful Days Payable only.
Days Payable range over the past 10 years
Min: 41.93, Med: 58.58, Max: 92.09
Current: 42.02
41.93
92.09

Dividend & Buy Back

Current vs industry vs history
3-Year Share Buyback Rate -0.60
3-Year Share Buyback Rate ranked higher than
95.90% of 244 companies
in the Medical Devices industry.
Industry Max: 19.2, Med: -5.7, Min: -1393.3
BABY: -0.6
Ranked among companies with meaningful 3-Year Share Buyback Rate only.
3-Year Share Buyback Rate range over the past 10 years
Min: -185.4, Med: -3.3, Max: -0.5
Current: -0.6
-185.4
-0.5

Valuation & Return

Current vs industry vs history
Price-to-Tangible-Book 10.17
Price-to-Tangible-Book ranked lower than
84.06% of 276 companies
in the Medical Devices industry.
Industry Max: 1180, Med: 4.5, Min: 0.07
BABY: 10.17
Ranked among companies with meaningful Price-to-Tangible-Book only.
Price-to-Tangible-Book range over the past 10 years
Min: 1.02, Med: 5.33, Max: 64.5
Current: 10.17
1.02
64.5
Price-to-Projected-FCF 1.31
Price-to-Intrinsic-Value-Projected-FCF ranked higher than
74.38% of 121 companies
in the Medical Devices industry.
Industry Max: 89.64, Med: 2.44, Min: 0.43
BABY: 1.31
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
Price-to-Intrinsic-Value-Projected-FCF range over the past 10 years
Min: 0.81, Med: 1.71, Max: 8.51
Current: 1.31
0.81
8.51
Price-to-Median-PS-Value 0.77
Price-to-Median-PS-Value ranked higher than
65.82% of 237 companies
in the Medical Devices industry.
Industry Max: 20.13, Med: 1.02, Min: 0.02
BABY: 0.77
Ranked among companies with meaningful Price-to-Median-PS-Value only.
Price-to-Median-PS-Value range over the past 10 years
Min: 0.15, Med: 1.11, Max: 3.25
Current: 0.77
0.15
3.25
Earnings Yield (Joel Greenblatt) % -6.41
Earnings Yield (Greenblatt) ranked higher than
50.90% of 332 companies
in the Medical Devices industry.
Industry Max: 158.73, Med: 0.74, Min: -2500
BABY: -6.41
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
Earnings Yield (Greenblatt) range over the past 10 years
Min: -7.2, Med: 4, Max: 19
Current: -6.41
-7.2
19
Forward Rate of Return (Yacktman) % -10.68
Forward Rate of Return ranked higher than
72.80% of 125 companies
in the Medical Devices industry.
Industry Max: 78.28, Med: 6.6, Min: -76.71
BABY: -10.68
Ranked among companies with meaningful Forward Rate of Return only.
Forward Rate of Return range over the past 10 years
Min: -11.7, Med: 9.6, Max: 23.4
Current: -10.68
-11.7
23.4

More Statistics

Revenue (TTM) (Mil) $ 517.04
EPS (TTM) $ -1.49
Beta 0.18
Volatility % 37.05
52-Week Range $ 23.58 - 37.95
Shares Outstanding (Mil) 34.01

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 5
Positive ROA N
Positive CFROA Y
Higher ROA yoy N
CFROA > ROA Y
Lower Leverage yoy Y
Higher Current Ratio yoy N
Less Shares Outstanding yoy N
Higher Gross Margin yoy Y
Higher Asset Turnover yoy Y